Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immunomedics
Morris Plains, New Jersey, United Statesimmunomedics.com ↗
- Ownership
- Public · IMMU
- Employees
- ~500
- Development stage
- Other
01
Overview
Immunomedics developed Trodelvy™ (sacituzumab govitecan-hziy), a first-in-class Trop‑2-directed ADC approved for third-line or later metastatic triple-negative breast cancer. The company had ongoing registrational studies in HR+/HER2– metastatic breast cancer and urothelial carcinoma, with clinical activity demonstrated across multiple other solid tumor types. Trodelvy showed significant efficacy benefit versus chemotherapy and was expected to become a standard of care in advanced TNBC.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Partnerships
Samsung Biologics as CMO for manufacturing support before the acquisition; no major pharma partnerships disclosed beyond parent company post-acquisition.
03
Financials
- Market cap
- $218.3M
- Total revenue
- $3.8M
- Enterprise value
- $437.2M
Beyond the preview
Go deeper on Immunomedics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunomedics.